{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:35:00Z","timestamp":1782509700232,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.msec.2017.03.065","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T10:03:16Z","timestamp":1489140196000},"page":"1496-1505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["3-month parenteral PLGA microsphere formulations of risperidone: Fabrication, characterization and neuropharmacological assessments"],"prefix":"10.1016","volume":"75","author":[{"given":"Sundeep","family":"Chaurasia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuchukuntla","family":"Mounika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasudha","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vure","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2017.03.065_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0924-977X(97)00045-X","article-title":"Guidelines for depot antipsychotic treatment in schizophrenia","volume":"8","author":"Kane","year":"1998","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.msec.2017.03.065_bb0010","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00003495-199447050-00004","article-title":"Depot antipsychotic drugs. Place in therapy","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.msec.2017.03.065_bb0015","first-page":"S29","article-title":"Choosing an atypical antipsychotic","volume":"17","author":"Sussman","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.msec.2017.03.065_bb0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003495-199448020-00009","article-title":"Risperidone: a review of its pharmacology and therapeutic potential in the treatment of schizophrenia","volume":"48","author":"Grant","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.msec.2017.03.065_bb0025","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1176\/appi.ajp.161.4.756-a","article-title":"Extrapyramidal syndrome and long-acting injectable risperidone","volume":"161","author":"Adamou","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.msec.2017.03.065_bb0030","first-page":"S80","article-title":"Pharmacological profile of risperidone","volume":"38","author":"Ereshefsky","year":"1993","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.msec.2017.03.065_bb0035","series-title":"The Merck Index, 13th Edition","volume":"1478","author":"Budavari","year":"2001"},{"key":"10.1016\/j.msec.2017.03.065_bb0040","series-title":"The Pharmacological Basis Of Therapeutics, 10th edition","volume":"279","author":"Hardman","year":"2001"},{"key":"10.1016\/j.msec.2017.03.065_bb0045","first-page":"18","article-title":"Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics","volume":"64","author":"Ereshefsky","year":"2003","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.msec.2017.03.065_bb0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jconrel.2008.08.012","article-title":"The origins and evolution of \u201ccontrolled\u201d drug delivery systems","volume":"132","author":"Hoffman","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2017.03.065_bb0055","series-title":"Long Acting Injections and Implants","first-page":"167","article-title":"Microsphere technologies","author":"Wang","year":"2012"},{"key":"10.1016\/j.msec.2017.03.065_bb0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.msec.2017.03.065_bb0065","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1517\/17425247.2012.709844","article-title":"Recent advances in polymeric microspheres for parenteral drug delivery-part 1","volume":"9","author":"Mao","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.msec.2017.03.065_bb0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0928-0987(02)00023-4","article-title":"PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release","volume":"15","author":"Faisant","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.msec.2017.03.065_bb0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2006.02.015","article-title":"Elevated temperature accelerated release testing of PLGA microspheres","volume":"112","author":"Zolnik","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2017.03.065_bb0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0168-3659(01)00403-5","article-title":"Preparation, characterization and in vivo evaluation of 120-day poly(d,l-lactide) leuprolide microspheres","volume":"75","author":"Woo","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2017.03.065_bb0090","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11095-005-9397-8","article-title":"Methods to assess in vitro drug release from injectable polymeric particulate systems","volume":"23","author":"D-Souza","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.msec.2017.03.065_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/620464","article-title":"Development of risperidone PLGA microspheres","volume":"2014","author":"D-Souza","year":"2014","journal-title":"J. Drug Del."},{"key":"10.1016\/j.msec.2017.03.065_bb0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2006.09.025","article-title":"Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats","volume":"330","author":"Maiti","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.03.065_bb0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.msec.2017.03.065_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2006.04.048","article-title":"Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat","volume":"540","author":"Naiker","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.msec.2017.03.065_bb0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00433091","article-title":"An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine","volume":"69","author":"Fray","year":"1980","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.msec.2017.03.065_bb0120","series-title":"Working Methods in Neuropharmacology","article-title":"Psychopharmacological studies in rodents: stereotaxic intracerebral injections and behavioral assessment","volume":"1","author":"Waddington","year":"1986"},{"key":"10.1016\/j.msec.2017.03.065_bb0125","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3797\/scipharm.0806-08","article-title":"Preparation and in vitro evaluation of a pegylated nano-liposomal formulation containing docetaxel","volume":"77","author":"Yousefi","year":"2009","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.msec.2017.03.065_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijbiomac.2015.11.084","article-title":"Cromolyn sodium encapsulated PLGA nanoparticles: an attempt to improve intestinal permeation","volume":"83","author":"Patel","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.msec.2017.03.065_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2007.01.016","article-title":"Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo","volume":"119","author":"Mittal","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2017.03.065_bb0140","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1166\/asl.2014.5478","article-title":"Optimization of parameters for the fabrication of curcumin loaded polymeric nanoparticles using taguchi robust design","volume":"20","author":"Chaurasia","year":"2014","journal-title":"Adv. Sci. Lett."},{"key":"10.1016\/j.msec.2017.03.065_bb0145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tca.2013.06.032","article-title":"Risperidone-solid-state characterization and pharmaceutical compatibility using thermal and non-thermal techniques","volume":"568","author":"Daniel","year":"2013","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.msec.2017.03.065_bb0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejpb.2015.01.029","article-title":"Thermodynamic phase behaviour of indomethacin\/PLGA formulations","volume":"93","author":"Prudic","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.msec.2017.03.065_bb0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijpharm.2013.05.020","article-title":"Modified emulsion solvent evaporation method for fabricating core-shell microspheres","volume":"452","author":"Xiao","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.03.065_bb0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2008.07.018","article-title":"Microencapsulation by solvent evaporation: state of the art for process engineering approaches","volume":"363","author":"Li","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.03.065_bb0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-3659(97)01647-7","article-title":"Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGAmicrospheres","volume":"47","author":"Sah","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2017.03.065_bb0170","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/03639045.2015.1064941","article-title":"Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies","volume":"42","author":"Chaurasia","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.msec.2017.03.065_bb0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.carbpol.2015.04.062","article-title":"Lipopolysaccharide based oral nanocarriers for improvement of bioavailability and anticancer efficacy of curcumin","volume":"130","author":"Chaurasia","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.msec.2017.03.065_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF01066595","article-title":"Application of the Loo-Riegelman absorption method","volume":"3","author":"Wagner","year":"1975","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.msec.2017.03.065_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2008.01.004","article-title":"Evaluation of in vivo\u2013in vitro release of dexamethasone from PLGA microspheres","volume":"127","author":"Zolnik","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2017.03.065_bb0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2006.06.032","article-title":"Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs","volume":"325","author":"Chu","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.03.065_bb0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2007.08.003","article-title":"In vitro and in vivo demonstration of risperidone implants in mice","volume":"98","author":"Rabin","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.msec.2017.03.065_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634146","article-title":"Climbing behaviour induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum","volume":"50","author":"Protais","year":"1976","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.msec.2017.03.065_bb0205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2217\/17435889.3.3.305","article-title":"Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation","volume":"3","author":"Muthu","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.msec.2017.03.065_bb0210","first-page":"S46","article-title":"Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug","volume":"39","author":"Keegan","year":"1994","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.msec.2017.03.065_bb0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.164.2.141","article-title":"The new atypical antipsychotics: a lack of extrapyramidal side-effects and new routes in schizophrenia research","volume":"164","author":"Kerwin","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.msec.2017.03.065_bb0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","article-title":"Intranasal nanoemulsion based brain targeting drug delivery system of risperidone","volume":"358","author":"Kumar","year":"2008","journal-title":"Int. J. Pharm."}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493116313613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493116313613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T17:54:54Z","timestamp":1601747694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493116313613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":43,"alternative-id":["S0928493116313613"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2017.03.065","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3-month parenteral PLGA microsphere formulations of risperidone: Fabrication, characterization and neuropharmacological assessments","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2017.03.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}